skip to primary navigation skip to content
 

 

You are not currently logged in

SPRI library catalogue

View a record

Please note: You are viewing the legacy database of the Scott Polar Research Institute Library catalogue. It is no longer being updated, so does not reliably reflect our current library holdings.

Please search for material in iDiscover for up-to-date information about the library collection.


Record #187247:

Vaccination policy and programs in the circumpolar world / P. Orr.

Title: Vaccination policy and programs in the circumpolar world / P. Orr.
Author(s): Orr, P.
Date: 2007.
In: International Journal of Circumpolar Health. (2007.), Vol. 66(5) (2007)
Abstract: Considers new vaccines against Pneumococcus, Meningococcus, Human Papilloma Virus (HPV) and Rotavirus currently being evaluated in circumpolar world. Argues that evaluation process should ensure that vaccine components and immunogenicity are suited to targeted Arctic population. Notes that, in Canada, licensed seven-valent pneumococcal conjugate vaccine does not include Serotype 1 which is significant cause of morbidity and mortality among Canadian aboriginal children.
Notes:

International Journal of Circumpolar Health. Vol. 66(5) :380-381 (2007).

Keywords: 32 -- Politics.
612.017 -- Immunity.
614 -- Public health and safety.
616-036 -- Epidemiology.
I -- Medicine and health.
(*3) -- Arctic regions.
SPRI record no.: 187247

MARCXML

LDR 01308naa#a2200000#a#4500
001 SPRI-187247
005 20220925125603.0
007 ta
008 220925s2007####xx####|##|###|0||#0|eng#d
035 ## ‡aSPRI-187247
040 ## ‡aUkCU-P‡beng‡eaacr
100 1# ‡aOrr, P.
245 10 ‡aVaccination policy and programs in the circumpolar world /‡cP. Orr.
260 ## ‡a[S.l.] :‡b[s.n.],‡c2007.
300 ## ‡ap. 380-381.
500 ## ‡aInternational Journal of Circumpolar Health. Vol. 66(5) :380-381 (2007).
520 3# ‡aConsiders new vaccines against Pneumococcus, Meningococcus, Human Papilloma Virus (HPV) and Rotavirus currently being evaluated in circumpolar world. Argues that evaluation process should ensure that vaccine components and immunogenicity are suited to targeted Arctic population. Notes that, in Canada, licensed seven-valent pneumococcal conjugate vaccine does not include Serotype 1 which is significant cause of morbidity and mortality among Canadian aboriginal children.
650 07 ‡a32 -- Politics.‡2udc
650 07 ‡a612.017 -- Immunity.‡2udc
650 07 ‡a614 -- Public health and safety.‡2udc
650 07 ‡a616-036 -- Epidemiology.‡2udc
650 07 ‡aI -- Medicine and health.‡2local
651 #7 ‡a(*3) -- Arctic regions.‡2udc
773 0# ‡7nnas ‡tInternational Journal of Circumpolar Health. ‡gVol. 66(5) (2007) ‡wSPRI-142401
916 ## ‡a2009/08/11 -- JW
917 ## ‡aUnenhanced record from Muscat, imported 2019
948 3# ‡a20220925 ‡bJW